• Why ChemoFx^®?
• Commitment to clinical proof
• ChemoFx^®
  clinical trials
• Indications & use
• Specimen handling
• Interpretation
  of results

The new ChemoFx^® report provides easy-to-read results of your patient's in vitro response to the chemotherapies you've chosen in three distinct categories: The second page of the report provides supplementary information for you using a bar graph. Each bar shows segments corresponding to the doses tested for each drug. The segments are ordered from dose 1 (the lowest concentration) at the bottom, to dose 10 (the highest concentration) at the top. Each segment represents the contribution of each dose to your patient's specific cancer's overall in vitro response to a drug.


Keep in mind: The most important part of the graph is the category into which the drug falls based on the cumulative effect of all 10 doses. For example, in the chart below, the most effective drugs for your patient would be carboplatin/paclitaxel and cisplatin/docetaxel, but you cannot use this to determine whether one of them will work better than the other.



Listed below are some of the most frequently asked questions about ChemoFx^® that a patient may ask. You may also want to direct them to the patient section of this web site for more detailed information written in patient-friendly language.

It's a test that determines how an individual cancer patient is likely to respond to various types of chemotherapy by testing the treatment options on that patient's cancer cells, before choosing one for the patient.

Unlike most chemosensitivity and resistance assays, ChemoFx^® can help your physician determine if your cancer is likely to be responsive to the chemotherapies your physician has chosen.

If your physician can access your tumor and is considering chemotherapy, then this test may be right for you. Keep in mind that leukemia and lymphoma are not tested at this time.

A portion of your cancer cells or fluid removed during your surgical procedure or biopsy is sent to the lab for testing. The cancer cells are grown in the laboratory and treated with a number of chemotherapies selected by your physician. After treatment of the cancer cells, a report of the cancer cell response to each drug is sent to your doctor. He or she may use the results to help determine the most appropriate treatment option for you.

The test will tell your physician which treatments your cancer responded to in the laboratory and which treatments your cancer did not respond to. This will help your physician determine the chemotherapy that is most likely to work for you and reduce the chances of receiving ineffective therapies that can lead to tumor progression, increased side effects, reduced effectiveness of future treatments and an overall decrease in your quality of life. On the other hand, there may be times when the results indicate that the cancer did not respond to any of the chosen chemotherapies, which is valuable information for your physician.

Your physician will get a copy of the results and will discuss the best treatment plan with you based on all the information available and his or her expertise—not just the results of the test.